Aurinia Pharmaceuticals (AUPH) PT Raised To $24 At Cantor On Voclosporin Notice Of Allowance

March 20, 2019 8:38 AM EDT Send to a Friend
Cantor Fitzgerald analyst Elemer Piros reiterated an Overweight rating and raised his price target to $24 from $18 on Aurinia ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login